Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 364 | 188 | 66 | 37 | 9 |
| Other Working Capital | -67 | -103 | 550 | 330 | 142 |
| Other Operating Activity | -775 | -383 | -1,089 | -770 | -486 |
| Operating Cash Flow | $-478 | $-298 | $-473 | $-402 | $-335 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -690 | -690 | -690 | N/A | N/A |
| Other Investing Activity | 22,361 | 182 | 1,337 | 38 | 33 |
| Investing Cash Flow | $21,671 | $-508 | $647 | $38 | $33 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 962 | 862 | 690 | N/A | N/A |
| Debt Repayment | -65 | -65 | N/A | N/A | N/A |
| Common Stock Repurchased | -22,099 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | -8 | -8 | -8 |
| Financing Cash Flow | $-21,202 | $797 | $683 | $-8 | $-8 |
| Beginning Cash Position | 11 | 11 | 449 | 449 | 449 |
| End Cash Position | 1 | 2 | 11 | 77 | 140 |
| Net Cash Flow | $-10 | $-9 | $-438 | $-372 | $-310 |
| Free Cash Flow | |||||
| Operating Cash Flow | -478 | -298 | -473 | -402 | -335 |
| Free Cash Flow | -478 | -298 | -473 | -402 | -335 |